Bristol Myers Squibb stock slips at the close
Published on 09/22/2026 at 23:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Bristol Myers Squibb stock closed at USD 62.68 on the NYSE on September 22, 2026, according to the session quote reported by MarketBeat. The stock traded USD 0.06 higher during Tuesday trading, while the S&P 500 fell 0.06 percent to 7,764.64.
September 22, 2026 in numbers
Bristol Myers Squibb Co. (ISIN US1101221083) reached USD 62.68 during the session, based on the MarketBeat report, which described the NYSE-listed shares as trading up USD 0.06. The stock therefore outperformed the S&P 500 by 0.06 percentage points on the available session comparison. The prior close was USD 62.62.
Clinical development of ORM-6151 was discontinued after Bristol Myers Squibb reviewed patient data, according to edaily. The program had been acquired from Orum Therapeutics and was being studied in a Phase 1 trial.
After the bell today
Bristol Myers Squibb was also named among companies joining the AISB Bind initiative, launched on September 22, 2026, according to Yahoo Finance. The initiative is scheduled to begin federated training in September, with final models expected in early 2027.
